We aim to assess the effects of non-pharmacological interventions for the treatment of memory problems in people with epilepsy. More specifically, we aim to evaluate whether people with epilepsy receiving one of these treatments:

1. may improve their memory, as measured by subjective patient-reports, objective memory assessments, or both;
2. may experience associated adverse effects;
3. may improve in other neuropsychological domains, as assessed by validated measures (memory problems can occur due to a large number of cognitive difficulties such as word finding or executive functioning problems);
4. may improve their quality of life, as measured by validated scales (memory is often reported as an important influence of individuals' quality of life);